Ibritumomab tiuxetan. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases7

Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Mantle-Cell Neutropenia Recurrence Neoplasm Recurrence, Local

Chemicals and Drugs10

Yttrium Radioisotopes Antibodies, Monoclonal Antigens, CD20 Antibodies, Monoclonal, Murine-Derived Podophyllotoxin Indium Radioisotopes Carmustine Antineoplastic Agents Zirconium Radiopharmaceuticals

Analytical, Diagnostic and Therapeutic Techniques and Equipment12

Radioimmunotherapy Salvage Therapy Treatment Outcome Disease-Free Survival Remission Induction Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Survival Rate Whole-Body Counting Radiometry Whole Body Imaging Radiation Dosage

Phenomena and Processes2

Tissue Distribution Radiation Dosage

Information Science1

Health Care4

Treatment Outcome Disease-Free Survival Survival Rate Radiation Dosage

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Yttrium Radioisotopes Radioimmunotherapy Lymphoma, Non-Hodgkin Lymphoma, Follicular Antibodies, Monoclonal Lymphoma, B-Cell Antigens, CD20 Antibodies, Monoclonal, Murine-Derived Podophyllotoxin Lymphoma, Mantle-Cell Indium Radioisotopes Salvage Therapy Treatment Outcome Carmustine Neutropenia Disease-Free Survival Recurrence Remission Induction Antineoplastic Combined Chemotherapy Protocols Neoplasm Recurrence, Local Antineoplastic Agents Combined Modality Therapy Survival Rate Whole-Body Counting Tissue Distribution Radiometry Zirconium Whole Body Imaging Radiation Dosage Radiopharmaceuticals

No FAQ available that match "ibritumomab tiuxetan"